Golden Heart Flower

Golden Heart Flower (Beijing) Medical Technology is a medical device company specializing in innovative treatments for structural heart disease and hypertrophic cardiomyopathy (HCM). The company is best known for developing the Liwen RF ablation system, a minimally invasive radiofrequency ablation technology designed to treat HCM by reducing myocardial thickness. This proprietary technology offers a safer alternative to traditional surgical myectomy and alcohol septal ablation, which are more invasive or carry higher risks. In addition to its HCM portfolio, Golden Heart Flower develops transcatheter mitral and tricuspid valve replacement systems to address valvular heart diseases. The company was acquired by Venus Medtech in 2020, integrating its specialized cardiovascular solutions into Venus Medtech's broader structural heart platform.